Healthcare -
Biotechnology - NASDAQ - US
$ 1.235
0.406 %
$ 258 M
Market Cap
-1.74
P/E
Price Target
Average
358.84%
Revenue Forecast
Estimate
19.41%
EBIT
Estimate
--0.41%
Net Income
Estimate
29.61%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sangamo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SGMO of $5.67 , with forecasts ranging from
a
low of
$2 to a high of $19 .
SGMO Lowest Price Target
Wall Street Target
2 USD
61.94%
SGMO Average Price Target
Wall Street Target
5.67 USD
358.84%
SGMO Highest Price Target
Wall Street Target
19 USD
1438.46%
REVENUE FORECAST
Revenue Forecast Chart SGMO
EBIT FORECAST
EBIT Forecast Chart SGMO
NET INCOME FORECAST
Net Income Chart SGMO